Dr. Estela Rodriguez

13.8K posts

Dr. Estela Rodriguez banner
Dr. Estela Rodriguez

Dr. Estela Rodriguez

@Latinamd

Associate Director Community Outreach- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed

Miami, FL Katılım Haziran 2012
3K Takip Edilen8.2K Takipçiler
Dr. Estela Rodriguez retweetledi
Toni Choueiri, MD
Toni Choueiri, MD@DrChoueiri·
This worries me. AI can only become better and better to fool us all. We lead by trust + integrity; we need more than ever better tools + accountability. This even passed @NEJM before being retracted….kudos to @NEJM editors for catching this shortly! nejm.org/doi/full/10.10…
Toni Choueiri, MD tweet mediaToni Choueiri, MD tweet media
English
9
22
115
24.7K
Dr. Estela Rodriguez
Dr. Estela Rodriguez@Latinamd·
Don’t miss this special #CincodeMayo @TumorBoardTues tomorrow w @NarjustFlorezMD and @NehemiasGuevar5 discussing #NeoADAURA #lcsm @EGFRResisters
#TumorBoardTuesday@TumorBoardTues

#TumorBoardTuesday 🫁 Early-stage #NSCLC is no longer just surgery ➕ chemo: Molecular testing now shapes curative-intent Tx decisions 🧬 📢Join us Tuesday, 05-05-26 at 8PM ET as @NarjustFlorezMD & @NehemiasGuevar5 🗣️EGFR+ Early #NSCLC RT and bring others into the discussion‼️

English
0
3
10
465
Dr. Estela Rodriguez retweetledi
Christine A. Garcia, MD, MPH
Christine A. Garcia, MD, MPH@christinemphmd·
New @Nature study: >50% of lung cancer metastases are seeded by other metastases, not the primary tumor. This "seeding from seeding" reveals a complex evolutionary cascade that allows cancer to colonize the body. nature.com/articles/s4158…
English
7
168
610
52.3K
Dr. Estela Rodriguez
Dr. Estela Rodriguez@Latinamd·
🎉🎉 Congratulations to our new incoming @HemOncMiami @SylvesterCancer Chief fellows @d_tuerff @AksheeBatra and Dr Robert Briski! 👉🏽Particularly excited that we are probably the only program with a dedicated Chief fellow of #SoMe & #communityengagement 💚🧡
Miami Hem/Onc Program Director@HemOncMiami

Excited to share our Hematology/Oncology Chief Fellows for 2026–27 🎉
Congratulations to Dr Robert Briski and Dr Daniel Tuerff @d_tuerff on this well-deserved recognition! Also thrilled to see Dr. Akshee Batra @AksheeBatra - lead Social Media & Community Engagement, advancing education, wellness and outreach. @SylvesterCancer @FLASCO_ORG @HemOncFellows

English
2
5
20
1.3K
Dr. Estela Rodriguez retweetledi
Miami Hem/Onc Program Director
Miami Hem/Onc Program Director@HemOncMiami·
Great roundtable with our fellows on insights, advice, and mentorship on publishing @JCO_ASCO , editorial pathways, and the art of impactful writing - paired with expert insights on lymphoma from @DrJFriedberg . Truly valuable mentorship and discussion! #Oncology #MedEd #AcademicMedicine @MikkaelSekeres @SylvesterCancer @Jani_Chinmay @dan_morgen @d_tuerff @AksheeBatra @Valardilaavila @JoseForeroMD
Miami Hem/Onc Program Director tweet mediaMiami Hem/Onc Program Director tweet media
English
0
4
26
3.1K
Dr. Estela Rodriguez
Dr. Estela Rodriguez@Latinamd·
Patients are also experts on their disease. Nice to see @EGFRResisters patient advocate @jillfeldman4 as an author of this comprehensive review of EGFR #lungcancer 🫁management. #lcsm
CA: A Cancer Journal for Clinicians@CACancerJournal

Mutations in the tyrosine kinase domain of EGFR represent one of the most common druggable alterations in #NSCLC. This recent review provides a comprehensive clinical overview of the management of patients with EGFR-mutant NSCLC. acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @OncoAlert @Alfdoc2

English
1
7
13
1.4K
Dr. Estela Rodriguez retweetledi
Hidehito HORINOUCHI
Hidehito HORINOUCHI@HHorinouchi·
🆙 #ASCO26 #LCSM Oral Abstract Session 🔥AcceleRET-Lung: Efficacy and Safety of Pralsetinib as First-Line Treatment of RET Fusion–Positive Advanced NSCLC 🎙️ @DrSanjayPopat 🔢8504 ☑️NCT04222972 🔗 asco.org/abstracts-pres… @OncoAlert @Larvol @ASCO
Hidehito HORINOUCHI tweet media
Hidehito HORINOUCHI@HHorinouchi

🆕 #ASCO25 🆙 ☑️#LCSM Poster 🔥Efficacy and safety of pralsetinib in patients with advanced RET-fusion-positive NSCLC: Final data from the phase 1/2 ARROW study 🎙️ @GlopesMd 📌Poster Bd124, Abstr8644 @OncoAlert @ASCO @Larvol meetings.asco.org/2025-asco-annu…

English
1
3
7
1.4K
Dr. Estela Rodriguez retweetledi
NEJM
NEJM@NEJM·
Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo. Full TRIDENT trial results and Research Summary: nejm.org/doi/full/10.10…
English
1
32
94
20.6K
Dr. Estela Rodriguez retweetledi
Aakash Desai, MD, MPH, FASCO
Aakash Desai, MD, MPH, FASCO@ADesaiMD·
🧬 My Top 10 DT abstracts at #ASCO2026 3 storylines I'm watching: → KRAS G12D: noncovalent DN022150 (Ph I/IIa) + RNK08954 (Ph II) in parallel → Macrocyclic EGFR arrives: BH-30643 FIH → Radioligand enters SCLC: 177Lu-DOTA-TATE in #SCLC @OncoAlert @oncodaily @Larvol
Aakash Desai, MD, MPH, FASCO tweet media
English
3
20
56
5.8K
Dr. Estela Rodriguez retweetledi
Hidehito HORINOUCHI
Hidehito HORINOUCHI@HHorinouchi·
🆙 #ASCO26 #LCSM Oral Abstract Session 🔥CROWN: Lorlatinib vs Crizotinib as First-Line Treatment for Advanced ALK+ NSCLC: 7-Year Update 🎙️ @TonyMok9 🔢8502 ☑️NCT03052608 🔗 asco.org/abstracts-pres… @OncoAlert @Larvol @ASCO
Hidehito HORINOUCHI tweet media
Hidehito HORINOUCHI@HHorinouchi

🔥#LBA8503 CROWN: Lorlatinib vs crizotinib, 5-year PFS 🎙️@bensolomon1👑😃 🎯Lorlatinib 5-y PFS 60% (95% CI, 51 to 68), mPFS not reached (NR [95% CI, 64.3 to NR]) ✅Phase III ✅Primary: PFS ✅NCT03052608 #ASCO24 @OncoAlert @ASCO doi.org/10.1200/JCO.24…

English
3
7
22
3.2K
Dr. Estela Rodriguez retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Retrospective matched cohort study associates cannabis use with higher risk of lung cancer (relative risk 3.87) across subtypes: SCLC RR 2.70, adenocarcinoma RR 2.54, squamous cell carcinoma RR 2.90. Need more study exploring biology here. lungcancerjournal.info/article/S0169-…
English
0
11
25
2.1K
Dr. Estela Rodriguez
Dr. Estela Rodriguez@Latinamd·
Happy Administrative Professionals Day to the unsung heroes of healthcare—the people who keep everything running behind the scenes and help manage the countless administrative tasks that make this job possible. Grateful for our incredible staff at @SylvesterCancer this week and every week. #AdministrativeProfessionalsDay
Dr. Estela Rodriguez tweet media
English
0
0
10
342
Dr. Estela Rodriguez
Dr. Estela Rodriguez@Latinamd·
@DrMarthaGulati Eye opening @Gallup survey results of reasons why patients are using AI Health information: speed of information but also lack of access, cost of healthcare and feeling dismissed or ignored by a physician in the past.
Dr. Estela Rodriguez tweet media
English
0
0
0
64
Dr. Estela Rodriguez retweetledi
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦@DrMarthaGulati·
This is remarkable but also true. This is why AI needs to be validated and the medical community needs to be a part of this to ensure we are meeting patients where they are. Which is on these apps, SoMe and the internet…. #AI #healthcare
Joel Selanikio@jselanikio

New poll from @Gallup and @WestHealth: 14 million clinic visits were skipped because Americans asked AI for health advice instead. Let that sink in: 14 MILLION visits. Per month. Right now. The U.S. generates ~89 million physician office visits per month. 14 million = about 16% of that. One in six. Gone.

English
6
12
29
6.8K

Keşfet

@NEJM @TumorBoardTues @NarjustFlorezMD @NehemiasGuevar5 @EGFRResisters @KentuckyDerby @Nature @KRASKickers